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Small interfering RNA (siRNA) based therapeutics for cancer treatments have gained 
considerable attention due to the high potency of siRNA in suppressing pathogenic gene 
expression [1]. Yet, there are drawbacks that limit siRNA application in vivo: the 
vulnerability of siRNA against nucleases and the inability of the nucleic acids molecules 
to diffuse across the cellular membranes [1]. Nanovectors hold great promise for 
overcoming these limitations towards the development of efficient siRNA therapy. 
Various nanovectors such as lipids, polymers and inorganic nano-particles have been 
extensively studied [2]. Among these nanovectors, mesoporous silica nanoparticles 
(MSN) show promising potential as the next-generation gene delivery carriers [3,4,5].  
 
The main prerequisite for gene therapy is the accumulation of the therapeutic agents on 
target cancer site [6], which can be achieved through the modification of MSN with 
targeting moieties such as biological ligand or magnetic particles. Numerous studies on 
the encapsulation of magnetic nanoparticles (iron oxide) within porous silica for drug 
delivery have been reported. However, study on MSN with large pores (> 3 nm, termed 
LPMSN) loaded with magnetic nanoparticles for siRNA delivery is still limited.   
This work reports the synthesis of novel polyethyleneimine (PEI) functionalized, and iron 
oxide nanoparticles loaded LPMSN (PEI-Fe-LPMSN) as a multifunctional nano-carrier 
for gene delivery. LPMSNs with a particle size around 200 nm,  a large pore size of 11 
nm and a pore connection size of 5 nm are used as a host to impregnate iron oxide 
nanoparticles inside the mesopores (Figure 1). The large pore in our study has  two 
advantages. Firstly, it provides adequate space for the formation of large iron oxide 
particles to enhance the magnetic properties. Secondly, the large pore as well as the 
connection size opens the possibility to adsorb  more siRNA molecules not only on the 
surface but also within the pores, which can enhance siRNA protection against 
biodegradation. 
 
 
Figure 1. Electron microscopy images for LPMSNs (A), Fe-LPMSN (B) and an ET 
(Electron Tomography) slice of Fe-LPMSN 
 
PEI is grafted on the silica pores (PEI-Fe-LPMSN) and surface to enhance the nano-
carrier’s affinity against genes and target the cell membrane. Furthermore, polyethylene 
glycol (PEG) is introduced into the hybrid nanoparticles to improve the biocompatibility 
and dispersibility. The products have been characterised with various instruments: X-ray 
photoelectron spectroscopy (XPS), solid-state 13C magic-angle spinning nuclear magnetic 
resonance (MAS-NMR), Elemental Analysis (EA) and thermogravimetric analysis 
(TGA). PEI functionalization significantly improves the interaction between the silica 
particles and oligo DNA / cell membrane, which enhances the cell uptake. The 
internalization of PEI-Fe-LPMSN can be accelerated by a magnetic field, which causes a 
high transfection within a short period of time. In addition, the PEGylated nanoparticles 
show a high biocompatibility. The multifunctional materials enable siRNA delivery 
within KHOS cancer line and achieve knockdown of PLK-1 oncogenes. 
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Dear Colleagues,  
Welcome to the International Conference on Nanotechnology in Medicine 
(NanoMED) held at University College London in London, United Kingdom. 
NanoMED has emerged from the highly successful NANOSMAT conference 
(www.nanosmat-conference.com), which is held each year, since 2005, in 
Europe, USA and now in Asia (Asia launch in 2013). I would like to thank Dr 
Nasar Ali, the founder and chairman of NANOSMAT, for his hard work in 
organising this extraordinary meeting.  
The conference will focus on five critically important areas of active and 
evolving research in the application of nanotechnology in medicine, with a full 
session devoted to each. The session themes are 1) Tissue Engineering & Biomedical Sciences, 2) Diagnosis 
and Imaging, 3) Drug Delivery, 4) Nanoscale Biomaterial Surface Modification and 5) Biosensors.  
On the first day of the meeting we have invited speakers in the scientific program to cover these topics, 
whereas, days 2 and 3 are dedicated to selected abstracted for oral as well poster presentations.  
The oral presentations are in two parallel sessions, which you should attend based on your preferred topic 
of interests. A dedicated poster session on first and second day will be held at 4:30 PM and will include 
poster presentations based on accepted abstracts chosen by the Program Committee based on scientific 
merit. I strongly encourage all participants to view the posters and discuss them with the authors (who 
should try to stand by them at the dedicated poster sessions). An exciting exhibit of "Artificial Human Body 
Parts" from “UCL Centre for Nanotechnology & Regenerative Medicine” research team will also be 
presented. The exhibit will demonstrate how nanotechnology played a big role on development of organs 
from laboratory into humans, including world first synthetic trachea, bypass graft, lacrimal duct, and other 
organs. There will also be an opportunity for a limited number of attendees to visit “UCL Centre for 
Nanotechnology & Regenerative Medicine” at Royal Free Campus, based at Hampstead, one of the most 
beautiful parts of London. 
The NanoMED conference is organized to bring together multidisciplinary experts in from wide 
backgrounds including academia, industry and government. We strive to promote dialogue and 
collaborations between scientists and clinicians, recognized scientific leaders and trainees, and among 
nanotechnologists, physicists, chemists, biologists, engineers, biomaterials researchers, surgeons and 
others whose work addresses fundamental aspects of nanomedicine. While the ambitious program is built 
around lectures from carefully selected speakers, the success of the meeting will reply on free flowing 
thought-provoking discussions and debates among all attendees and the generation of cross fertilizing new 
collaborations and new synergies that facilitate the successful application of nanotechnology in medicine. 
London is a dynamic city and Bloomsbury is centrally situated making exploration of the city quite 
accessible. Bloomsbury has a remarkable literary heritage and the British Museum is a short walk away 
from the conference venue. The facilities of the recently concluded Olympic Games are a short tube ride 
away. I hope you will find time before or after the conference to explore this exciting city.  
Thank you for participating in this exciting conference. The NanoMED has many new programs in 
development and I strongly encourage all participants to remain active in this extraordinary Society.  
 
Best Wishes, 
 
Alexander Marcus Seifalian (Chair), Professor of Nanotechnology & Regenerative Medicine, UCL, UK 
Jawwad Darr (Co-chair), Professor of Chemistry, UCL, UK 
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9
th
 November 2012 
Time Topic: Drug delivery (Nano-vehicle 
delivery systems) 
Chair: Prof. Stanislaw Mitura (Poland) 
Room: Old Refectory  
Time Topic: Diagnosis and Imaging 
Chair: Prof. Chia-Liang Cheng (Taiwan)   
 
Room: Chadwick Lecture Theatre  
09:00 - 
09:20 
 
NANO-126: Sandy Budi Hartono, The 
University of Queensland, Australia 
"Multifunctional Large Pore Mesoporous 
Silica Nanoparticles as a novel gene 
carrier" 
09:00 - 
09:20 
 
NANO-10: M. Clara Gonçalves, Technical 
University of Lisbon, Portugal 
"Potentiality of ORMOSIL nanoparticles as 
negative Contrast Agents for MRI" 
09:20 - 
09:40 
 
NANO-188: Francesca Baldelli Bombelli, 
University of East Anglia, UK 
"Development of Engineered Nanocarriers 
for the Treatment of Metastatic 
Melanoma" 
09:20 - 
09:40 
 
NANO-116: Elnaz Yaghini, University College 
London, UK 
"Cadmium Free Quantum Dots as a Novel 
Fluorescence Probe for In Vivo Sentinel Lymph 
Node Imaging" 
09.40 - 
10.00 
 
 
 
 
 
NANO-92: Petr Toman, University of 
Portsmouth, UK 
"Nanoparticles of Alkylglyceryl-Dextran-
poly(lactic acid) for Drug Delivery to The 
Brain" 
09.40 - 
10.00 
 
 
 
 
 
NANO-118: Maria Luisa Bondì, Consiglio 
Nazionale delle Ricerche, Istituto per lo Studio dei 
Materiali Nanostrutturati, Italy 
"Oligonucleotide-decorated carboxyl-modified PVP 
nanogels: a new platform for diagnosis and gene-
therapy" 
10.00 - 
10.20 
 
 
 
NANO-35: Ana Maria Carmona-Ribeiro, 
Universidade de São Paulo, Brazil 
"Supramolecular assemblies of cationic 
lipid and gramicidin as microbicidal agents" 
10.00 - 
10.20 
 
 
 
NANO-186: Samir Iqbal, University of Texas at 
Arlington, USA 
"Isolation and Typing of Tumour Cells from Images 
of Aptamer-Functionalized Chips" 
10.20 - 
10.40 
 
NANO-153: Margaret Holme, University of 
Basel, Switzerland 
"Shear stress sensitive nanocontainers with 
tunable release properties" 
10.20 - 
10.40 
 
NANO-28: Jiunn-Der Liao, National Cheng Kung 
University, Taiwan 
"SERS-based DNA detection using inverted multi-
angular Au nano-cavity array-embedded 
microfluidic divice" 
10.40 - 
11.00 
NANO-179: David Cramb, University of 
Calgary, Canada 
"Critical factors in nanoparticle drug 
delivery design" 
10.40 - 
11.00 
 
NANO-31: Kevin Critchley, Molecular and 
Nanoscale Physics Group, UK 
"Cadmium Free Quantum Dots " 
11:00 - 
11:30 
Refreshments break 
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Time Topic: Tissue Engineering & 
Biomedical Sciences 
Chair:  Dr Brian Cousin (UK)   
Room: Old Refectory  
Time Topic: Diagnosis and Imaging 
Chair: Prof. Ueli Aebi (Switzerland)   
 
Room: Chadwick Lecture Theatre 
11:30 - 
11:50 
 
NANO-149: Volker Mailänder, Max Planck 
Institute for Polymer Research, Germany 
"Specific targeting by (oligo)mannose 
functionalized hydroxyethyl starch 
nanocapsules: en route to drug delivery 
systems with targeting properties" 
11:30 - 
11:50 
 
NANO-55: Manlio Tassieri, University of Glasgow, 
UK 
"Measuring the viscous and elastic properties of 
single cells using particle tracking microrheology" 
11:50 - 
12:10 
 
NANO-32: Angel Millan, Universidad de 
Zaragoza, Spain 
"Multifunctional Nanoplatform for 
Biomedical Applications" 
11:50 - 
12:10 
 
NANO-58: Alessandra Bestetti, The University of 
Melbourne, Australia 
"A Versatile and Widely Applicable Strategy for the 
Conjugation of Quantum Dots to Biomolecules 
through Click Chemistry" 
12:10 - 
12:30 
 
NANO-17: Vesselin N Paunov, University of 
Hull, UK 
"Encapsulation of Living Cells into 
Sporopollenin Microcapsules" 
12:10 - 
12:30 
 
NANO-63: E. Castro, University of Minho, Portugal 
"Could anisotropic iron oxide nanoparticles lead to 
further enhancing in magnetic resonance 
imaging?" 
12:30 - 
12:50 
 
 
NANO-194: Raffaella Aversa, Second 
University of Naples, Italy 
"Mechanical and Swelling Behaviour of 
New Hybrid Ceramo-Polymeric bio-
nanocomposites" 
12:30 - 
12:50 
 
 
NANO-82: Jérémy Paris, Université de Bourgogne, 
France 
"Bimodal Contrast Agents for the in Vivo Imaging: 
The Elaboration of Functionalized 
SuperParamagnetic Iron Oxide Nanoparticles" 
12:50 - 
14:00 
LUNCH 
Time Topic: Tissue Engineering & Biomedical 
Sciences 
Chair: Prof. Jawwad A. Darr (UK)   
Room: Old Refectory  
Time Topic: Diagnosis and Imaging 
Chair: Dr Nasar Ali (UK)  
Room: Chadwick Lecture Theatre  
14:00 - 
14:20 
 
NANO-25: Mohd Zobir Hussein, Universiti 
Putra Malaysia, Malaysia 
"Zinc Layered Hydroxide-Salicylate 
Nanohybrid and Its Effect on Vero3 Cells 
Viability" 
14:00 - 
14:20 
 
NANO-85: Julien Boudon, Université de 
Bourgogne, France 
"Biodistribution Study of a Novel Theranostic 
Versatile Platform Composed of Surface-modified 
Titanate Nanotubes" 
14:20 - 
14:40 
 
NANO-16: Vesselin N Paunov, University of 
Hull, UK 
"Triggered Cell Release from Shellac-Cells 
Composite Microcapsules" 
14:20 - 
14:40 
 
NANO-86: John Wang, National University of 
Singapore, Singapore 
"Multifunctional Hybrid Nano Core@shells via 
Bioinspired Silification for Targeted Diagnosis" 
14:40 - 
15:00 
 
NANO-52: Cynthia Wong, Deakin 
University, Australia 
"Potential of electrospun polyurethane 
blended with elastin and collagen as 
vascular graft" 
14:40 - 
15:00 
 
NANO-96: Yang Liu, Loughborough University, UK 
"AFM Measurement of Single Cell Mechanical 
Properties of Live, Membrane-Impaired and Dead 
Human Mesenchymal Stem Cells" 
 
